BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Cellectis 

8 rue de la Croix Jarry

Paris    75013  France
Phone: 33-0-1-81-69-16-00 Fax: n/a


SEARCH JOBS




Industry
Biotechnology

Segment
Genomics





 Company News
Cellectis (ALCLS) Combined General Shareholders' Meeting Of May 18, 2015 5/20/2015 9:26:05 AM
Cellectis (ALCLS) To Present Data On Genome Engineering For Adoptive Immunotherapy At The ASCO Annual Meeting 5/14/2015 12:25:51 PM
Cellectis (ALCLS) Announces Presentations At Upcoming Conferences 4/10/2015 11:27:15 AM
Cellectis (ALCLS) Opens Up Shop and Brings Engineered CAR-T Therapy to the Big Apple 4/9/2015 5:22:09 AM
Cellectis (ALCLS) Prices Initial Public Offering Of American Depositary Shares 3/25/2015 1:00:38 PM
Nasdaq Welcomes Cellectis (ALCLS) The Nasdaq Stock Market 3/25/2015 9:39:08 AM
Cancer Biotech Cellectis (ALCLS) Sets Terms For $129 Million IPO 3/20/2015 6:36:40 AM
ModiQuest Research And Cellectis (ALCLS) To Collaborate On Antibody Generation For Potential CAR Development 3/6/2015 9:29:48 AM
Cellectis (ALCLS): 2014 Financial Results 3/5/2015 11:02:46 AM
Cellectis (ALCLS) And Ohio State University, Through The Ohio State Innovation Foundation, Enter Into Licensing Agreement For Chimeric Antigen Receptor Technology Targeting Multiple Myeloma 1/13/2015 11:38:46 AM
12345678910...